| Home-based maintenance tele-rehabilitation reduces the risk for acute exacerbations of COPD, hospitalisations and emergency department visits M Vasilopoulou, AI Papaioannou, G Kaltsakas, Z Louvaris, N Chynkiamis, ... European Respiratory Journal 49 (5), 2017 | 233 | 2017 |
| The role of leptin in the respiratory system: an overview F Malli, AI Papaioannou, KI Gourgoulianis, Z Daniil Respiratory research 11, 1-16, 2010 | 192 | 2010 |
| Eosinophilic and noneosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort LG Heaney, LP de Llano, M Al-Ahmad, V Backer, J Busby, GW Canonica, ... Chest 160 (3), 814-830, 2021 | 172 | 2021 |
| Clinical implications for vascular endothelial growth factor in the lung: friend or foe? AI Papaioannou, K Kostikas, P Kollia, KI Gourgoulianis Respiratory research 7, 1-13, 2006 | 159 | 2006 |
| Oxidative stress dependent microRNA-34a activation via PI3Kα reduces the expression of sirtuin-1 and sirtuin-6 in epithelial cells JR Baker, C Vuppusetty, T Colley, AI Papaioannou, P Fenwick, ... Scientific reports 6 (1), 35871, 2016 | 155 | 2016 |
| Serum uric acid as a predictor of mortality and future exacerbations of COPD K Bartziokas, AI Papaioannou, S Loukides, A Papadopoulos, A Haniotou, ... European respiratory journal 43 (1), 43-53, 2014 | 133 | 2014 |
| Discrimination of exudative pleural effusions based on multiple biological parameters ZD Daniil, E Zintzaras, T Kiropoulos, AI Papaioannou, A Koutsokera, ... European Respiratory Journal 30 (5), 957-964, 2007 | 130 | 2007 |
| Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis ZD Daniil, E Papageorgiou, A Koutsokera, K Kostikas, T Kiropoulos, ... Pulmonary pharmacology & therapeutics 21 (1), 26-31, 2008 | 121 | 2008 |
| The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations AI Papaioannou, K Bartziokas, S Tsikrika, F Karakontaki, E Kastanakis, ... European Respiratory Journal 41 (4), 815-823, 2013 | 117 | 2013 |
| An algorithmic approach for the treatment of severe uncontrolled asthma E Zervas, K Samitas, AI Papaioannou, P Bakakos, S Loukides, M Gaga ERJ open research 4 (1), 2018 | 106 | 2018 |
| Systemic and airway inflammation and the presence of emphysema in patients with COPD AI Papaioannou, A Mazioti, T Kiropoulos, I Tsilioni, A Koutsokera, ... Respiratory medicine 104 (2), 275-282, 2010 | 106 | 2010 |
| Defining a severe asthma super-responder: findings from a Delphi process JW Upham, C Le Lievre, DJ Jackson, M Masoli, ME Wechsler, DB Price, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (11), 3997-4004, 2021 | 103 | 2021 |
| Clinical, functional and biochemical changes during recovery from COPD exacerbations A Koutsokera, TS Kiropoulos, DJ Nikoulis, ZD Daniil, V Tsolaki, K Tanou, ... Respiratory medicine 103 (6), 919-926, 2009 | 98 | 2009 |
| Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis AI Papaioannou, E Zakynthinos, K Kostikas, T Kiropoulos, A Koutsokera, ... BMC pulmonary medicine 9, 1-8, 2009 | 94 | 2009 |
| Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma: comparison with different sputum phenotypes P Ntontsi, S Loukides, P Bakakos, K Kostikas, G Papatheodorou, ... Allergy 72 (11), 1761-1767, 2017 | 87 | 2017 |
| The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma K Pappas, AI Papaioannou, K Kostikas, N Tzanakis Cytokine 64 (3), 613-625, 2013 | 85 | 2013 |
| Survival in idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach SA Papiris, K Kagouridis, L Kolilekas, AI Papaioannou, A Roussou, ... BMC pulmonary medicine 15, 1-9, 2015 | 83 | 2015 |
| Statins and outcome after hospitalization for COPD exacerbation: a prospective study K Bartziokas, AI Papaioannou, M Minas, K Kostikas, W Banya, ZD Daniil, ... Pulmonary pharmacology & therapeutics 24 (5), 625-631, 2011 | 83 | 2011 |
| Control of asthma in real life: still a valuable goal? AI Papaioannou, K Kostikas, E Zervas, L Kolilekas, S Papiris, M Gaga European Respiratory Review 24 (136), 361-369, 2015 | 81 | 2015 |
| Global assessment of the COPD patient: time to look beyond FEV1? AI Papaioannou, S Loukides, KI Gourgoulianis, K Kostikas Respiratory medicine 103 (5), 650-660, 2009 | 80 | 2009 |
Konstantinos KostikasRespiratory Medicine Department University of Ioannina Medical School在 uoi.gr 的电子邮件经过验证
